Last reviewed · How we verify
VT301
At a glance
| Generic name | VT301 |
|---|---|
| Sponsor | VTBIO Co. LTD |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of Possibility of Using Regulatory T Cells(VT301) for Treatment of Alzheimer's Disease (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- VT301 CI brief — competitive landscape report
- VT301 updates RSS · CI watch RSS
- VTBIO Co. LTD portfolio CI